Abstract
Congenital insensitivity to pain with anhidrosis (CIPA) is an autosomal recessive
disorder caused by mutations in the neurotrophic tyrosine receptor kinase 1 (NTRK1)
gene which encodes the receptor for nerve growth factor (NGF). We report the clinical
course in three sibs with CIPA and proven NTRK1 gene mutations with a follow-up over
a 25-year period in one of them. They had the characteristic clinical features of
an abnormally high pain threshold, and mental retardation; in addition their clinical
course was marked by the occurrence of early onset renal disease with recurrent microhematuria
and proteinuria and frequent observations of increased serum creatinine and blood
urea levels. Light microscopy study of a renal biopsy performed in one of them at
age of 20 months showed focal glomerulosclerosis, interstitial fibrosis and tubular
atrophy. This patient and his younger brother died because of renal failure at the
age of 25 years and 14 years, respectively. The sister still alive showed renal impairment
and deep venous thrombosis associated with lupus anticoagulant activity, decrease
of circulating autoreactive CD5+ B lymphocytes and increased urinary levels of IgG and κ and λ light chains, suggesting
a possible defect in regulation of B‐lymphocyte function. In the light of the NGF‐related
molecular defect, the extraneurological tissue involvement in CIPA might in part reflect
dysregulation of immune mechanisms which possibly brings about a chronic inflammatory
response. This, in turn, could result in renal disease which should be mentioned among
the life-threatening complications associated with this disorder.
Key words
CIPA - NGF receptor - NTRK1 mutation - long-term follow up - renal disease
References
1
Bonkowsky J L, Johnson J, Carey J C, Smith A G, Swoboda K J.
An infant with primary tooth loss and palmar hyperkeratosis: a novel mutation in the
NTRK1 gene causing congenital insensitivity to pain with anhidrosis.
Pediatrics.
2003;
112
237-241
2
Drummond R P, Rose G K.
A twenty-one-year review of a case of congenital indifference to pain.
J Bone Joint Surg [Br].
1975;
57
241-243
3 Dyck P J.
Neuronal atrophy and degeneration predominantly affecting peripheral sensory and autonomic
neurons. Dyck PJ, Thomas PK, Griffin JW, Low PA, Podreslo JC Peripheral Neuropathy. Philadelphia;
WB Saunders 1993: 1065-1093
4
Hirsch E, Moye D, Dimon J H.
Congenital indifference to pain: long-term follow-up of two cases.
South Med J.
1995;
88
851-857
5
Horigome K, Pryor J C, Bullock E D, Johnson E M.
Mediator release from mast cells by nerve growth factor. Neurotrophin specificity
and receptor mediation.
J Biol Chem.
1993;
268
14881-14887
6
Indo Y, Mardy S, Miura Y. et al .
Congenital insensitivity to pain with anhidrosis (CIPA): novel mutations of the TRKA
(NTRK1) gene, a putative uniparental disomy, and a linkage of the mutant TRKA and
PKLR genes in a family with CIPA and pyruvate kinase deficiency.
Hum Mutat.
2001;
18
308-318
7
Indo Y, Tsuruta M, Hayashida Y. et al .
Mutations in the TRKA/NGF receptor gene in patients with congenital insensitivity
to pain with anhidrosis.
Nat Genet.
1996;
13
485-488
8
Levi-Montalcini R, Skaper S D, Dal Toso R, Petrelli L, Leon A.
Nerve growth factor: from neurotrophin to neurokine.
Trends Neurosci.
1996;
19
514-520
9
Miranda C, Di Virgilio M, Selleri S. et al .
Novel pathogenic mechanisms of congenital insensitivity to pain with anhidrosis genetic
disorder unveiled by functional analysis of neurotrophic tyrosine receptor kinase
type 1/nerve growth factor receptor mutations.
J Biol Chem.
2002;
277
6455-6462
10
Pavone L, Huttenlocher P, Siciliano L. et al .
Two brothers with a variant of hereditary sensory neuropathy.
Neuropediatrics.
1992;
23
92-95
11
Pearson J, Gallo G, Gluck M, Axelrod F.
Renal disease in familial dysautonomia.
Kidney Int.
1980;
17
102-112
12
Roberts I S, Brenchley P E.
Mast cells: the forgotten cells of renal fibrosis.
J Clin Pathol.
2000;
53
858-862
13
Shatzky S, Moses S, Levy J. et al .
Congenital insensitivity to pain with anhidrosis (CIPA) in Israeli-Bedouins: genetic
heterogeneity, novel mutations in the TRKA/NGF receptor gene, clinical findings, and
results of nerve conduction studies.
Am J Med Genet.
2000;
19
353-360
14
Torcia M, de Chiara G, Nencioni L. et al .
Nerve growth factor inhibits apoptosis in memory B lymphocytes via inactivation of
p 38 MAPK, prevention of Bcl-2 phosphorylation, and cytochrome C release.
J Biol Chem.
2001;
276
39027-39036
15
Toscano E, della Casa R, Mardy S. et al .
Multisystem involvement in congenital insensitivity to pain with anhidrosis (CIPA),
a nerve growth factor receptor (TRK A)-related disorder.
Neuropediatrics.
2000;
31
39-41
Dr. Piero Pavone
Department of Pediatrics University of Catania
Via S. Sofia, 78
95125 Catania
Italy
Email: ppavone@unict.it